NRW.BANK
VC Fund
Düsseldorf, Germany
NRW.BANK is a VC fund in Düsseldorf focused on Software and Biotechnology. NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks.
- Total investments:
- 138
- Last investment:
- Lead investor:
- 24%
- Fund size:
- $163M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries NRW.BANK invests in
Stages NRW.BANK invests in
Countries NRW.BANK invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Seed
- $219k–$7.7M
- Pre-Seed
- $209k–$2.1M
- Series A
- $2.4M–$36M
Investment Focus
Industry
- Software 24 (17%)
- Biotechnology 17 (12%)
- Information Technology 17 (12%)
- Health Care 13 (9%)
- Artificial Intelligence 13 (9%)
Stage
- Seed 35 (25%)
- Series A 22 (16%)
- Pre-Seed 18 (13%)
- Series B 15 (11%)
- Funding Round 12 (9%)
Country
- Germany 94 (68%)
- United States 2 (1%)
- France 1 (1%)
- Switzerland 1 (1%)
- United Kingdom 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Aristotelis Nastos
Head of Life Sciences & Cleantech
|
Head of Life Sciences & Cleantech | Total investments: 3 | Find email | |
Claas Heise
Executive Director
|
Executive Director | Total investments: 0 | Find email | |
Dietrich Suhlrie
Member of the Managing Board
|
Member of the Managing Board | Total investments: 0 | Find email | |
Eckhard Forst
Chairman of the Managing Board
|
Chairman of the Managing Board | Total investments: 0 | Find email | |
Gabriele Pantring
Member of the Managing Board
|
Member of the Managing Board | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| NUNOS develops biological treatment systems that convert livestock slurry into liquid fertilizer and recycle nitrogenous wastewater. | $654.8K / Pre-Seed / Sep 18, 2026 | ||
| syte simplifies real estate decisions with AI-based software. Founded in 2021 and based in Münster, Germany, the company analyzes land and buildings in real time and makes complex real estate analyses easily accessible. The syte platform offers digital twins by intelligently linking various types of data, including cadastral and LiDAR data, aerialand satellite images, and market data. The database enables informed statements to be made about development opportunities, renovation potential, energy requirements, economic efficiency, and subsidy options.Project developers, real estate agents, and banks use syte for valuations, planning, and consulting. This includes evaluating locations, reviewing investment decisions, analyzing portfolios with regard to renovation needs, and identifying subsidies. Instead of time-consuming individual research or external expert opinions, the platform enables a reliable initial assessment.The team of over 30 people led by founders Matthias Zühlke and David Nellessen serves over 200 customers – from local real estate agencies to banks with thousands of properties. syte has received multiple awards for its innovative software, including the German AI Award 2023 and the PropTech of the Year Award 2025. | $10.3M / Series A / Sep 17, 2026 | ||
| PhageStack GmbH develops a computational platform that applies machine learning to screen, identify, and analyze specific bacteriophages. This technical infrastructure is built to help research partners accelerate the discovery of targeted biological options against antibiotic-resistant bacteria. | Pre-Seed / Sep 09, 2026 | ||
| Skylance develops counter-unmanned aerial systems for military and public-security users. Its products include close-range kinetic interceptors designed for Class 1 drones and a modular launcher that supports shoulder-mounted, tripod, and vehicle-integrated configurations. The company describes its systems as software-defined and compatible withexisting command-and-control structures. Its stated operating range for close-range interception is 100 to 1,200 meters. | $1.2M / Seed / Sep 03, 2026 | ||
| ag-tech.systems GmbH designs and manufactures tractor-mounted agricultural machinery that utilizes high-voltage electricity and a specialized conductive fluid to eliminate weeds and dry crops without synthetic chemicals. Their core value proposition centers on delivering a scalable, weather-independent alternative to chemical herbicides, enablingresidue-free harvesting and helping growers align with modern pesticide reduction regulations. The company monetizes its technology via outright machine sales, direct equipment rentals, and commercial leasing structures aimed at both private farmers and third-party service operators. | Seed / Aug 21, 2026 | ||
| info@amberoad.aiambeRoad is developing an intelligent enterprise search engine to help employees to find all relevant documents easily and quickly by integrating all company internal data sources into one search engine. Our solution allows access to all company-wide files from anywhere. Even if you don't exactly know what you are lookingfor, our cutting-edge AI will know because of a range of features implemented in our software.No need to tag documents manually, all in milliseconds - only one search request away. | $8.1M / Series A / Aug 17, 2026 | ||
| ENTRYZERO is a cybersecurity startup that develops an AI-powered software platform specializing in Threat Exposure Management,the company helps organizations continuously monitor their digital attack surface from a hacker’s perspective to identify and mitigatevulnerabilities automatically. | Seed / Jun 25, 2026 | ||
| NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics. | $33.6M / Series B / May 28, 2026 | ||
| eleQtron creates and operates quantum computers based on trapped ions, radio frequency control, and Magnetic Gradient Induced Coupling (MAGIC). It also puts forward novel ideas for scalable quantum processors based on RF-controlled trapped ions. eleQtron will run MAGIC quantum computers and provide quantum computing performance on a subscriptionbasis. | $66.6M / Series A / May 05, 2026 | ||
| Odacova is a SaaS company that provides individualized nutrition for corporate cafeterias and employee eating, utilizing web, Android, and iOS platforms. | Seed / Apr 28, 2026 | ||
| See all 138 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does NRW.BANK invest in?
NRW.BANK invests primarily in Software, Biotechnology and Information Technology startups, most often at Seed and Series A stage. Most of the 138 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is NRW.BANK's check size?
NRW.BANK typically joins rounds of $219k–$7.7M at Seed, $209k–$2.1M at Pre-Seed and $2.4M–$36M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds NRW.BANK participates in.
How do I contact NRW.BANK?
Public channels for NRW.BANK include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at NRW.BANK?
The team at NRW.BANK includes Aristotelis Nastos (Head of Life Sciences & Cleantech), Claas Heise (Executive Director) and Dietrich Suhlrie (Member of the Managing Board), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
